About 110 search results for "valsartan"

24:00 CARDIOVASCULAR DRUGS

https://www.canada.ca/en/indigenous-services-canada/services/non-insured-health-benefits-first-nations-inuit/benefits-services-under-non-insured-health-benefits-program/drugs-pharmacy-benefits/drug-benefit-list/dbl-24-eng.html

Nov 5, 2019 ...The Non-Insured Health Benefits (NIHB) Program of Health Canada provides coverage for approximately 824,033 eligible registered First Nations and recognized Inuit with a limited range of medically necessary health-related goods and services not provided through private or provincial/territorial health insurance plans. These benefits complement provincial and...

Expansion of recall of valsartan drugs to include additional lots, as a precaution

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2018/67552a-eng.php

Dec 18, 2018 ...Expansion of recall of valsartan drugs to include additional lots, as a precaution Report a Concern Starting date: August 18, 2018 Type of communication: Information Update Subcategory: Drugs Source of recall: Health Canada Issue: Important Safety Information Audience: General Public Identification number: RA-67552 Media enquiries Public enquiries Update

Product monograph brand safety updates

https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database/label-safety-assessment-update/product-monograph-brand-safety-updates.html

Nov 14, 2019 ... Inc No Yes No No No No No Yes Cipro, Cipro Oral Suspension 219636 ciprofloxacin Bayer Inc No Yes No No No No No Yes Cubicin, Cubicin RF 214792 daptomycin Cubist Pharmaceuticals Llc No Yes No Yes No Yes No Yes Depakene 221688 valproic acid BGP Pharma Ulc Yes Yes Yes Yes No Yes No Yes Diovan-HCT 221691 hydrochlorothiazide, valsartan Novartis Pharmaceuticals

Expansion of recall of valsartan drugs to include additional lots, as a precaution

http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2018/67552a-eng.php

Dec 18, 2018 ...Expansion of recall of valsartan drugs to include additional lots, as a precaution Report a Concern Starting date: August 18, 2018 Type of communication: Information Update Subcategory: Drugs Source of recall: Health Canada Issue: Important Safety Information Audience: General Public Identification number: RA-67552 Media enquiries Public enquiries Update

Impurities found in certain angiotensin II receptor blocker (ARB) products, also known as sartans

https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/information-health-product/drugs/angiotensin-receptor-blocker.html

Apr 29, 2019 ...Impurities found in certain angiotensin II receptor blocker (ARB) products, also known as sartans Table of Contents Overview Recalls Test Results Test Method Health Canada Communications Overview In the summer of 2018, several valsartan products were recalled in Canada and worldwide because of the impurity, N-nitrosodimethylamine (NDMA), found in the active

Information Update - Mylan-Valsartan medications voluntarily recalled as a precaution due to an impurity

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2018/68448a-eng.php

Nov 28, 2018 ...Information Update - Mylan-Valsartan medications voluntarily recalled as a precaution due to an impurity Report a Concern Starting date: November 28, 2018 Type of communication: Information Update Subcategory: Drugs Source of recall: Health Canada Issue: Important Safety Information Audience: General Public Identification number: RA-68448 What you should do

Health Canada advises of a second impurity linked to recalled valsartan drugs

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2018/67746a-eng.php

Sep 13, 2018 ...Health Canada advises of a second impurity linked to recalled valsartan drugs Report a Concern Starting date: September 13, 2018 Type of communication: Information Update Subcategory: Drugs Source of recall: Health Canada Identification number: RA-67746 Issue What you should do Media enquiries Public enquiries Issue OTTAWA - Health Canada is advising

Health Canada advises of a second impurity linked to recalled valsartan drugs

http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2018/67746a-eng.php

Sep 13, 2018 ...Health Canada advises of a second impurity linked to recalled valsartan drugs Report a Concern Starting date: September 13, 2018 Type of communication: Information Update Subcategory: Drugs Source of recall: Health Canada Identification number: RA-67746 Issue What you should do Media enquiries Public enquiries Issue OTTAWA - Health Canada is advising

Teva Valsartan Product Recall (2018-07-09)

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2018/67514r-eng.php

Aug 16, 2018 ...Teva Valsartan Product Recall (2018-07-09) Report a Concern Starting date: July 9, 2018 Type of communication: Drug Recall Subcategory: Drugs Hazard classification: Type I Source of recall: Health Canada Issue: Product Safety Audience: General Public, Healthcare Professionals, Hospitals Identification number: RA-67514 Reason Depth of distribution Affected

Sivem Valsartan Product Recall (2018-07-09)

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2018/67512r-eng.php

Aug 16, 2018 ...Sivem Valsartan Product Recall (2018-07-09) Report a Concern Starting date: July 9, 2018 Type of communication: Drug Recall Subcategory: Drugs Hazard classification: Type I Source of recall: Health Canada Issue: Product Safety Audience: General Public, Healthcare Professionals, Hospitals Identification number: RA-67512 Reason Depth of distribution Affected

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: